 |
|
|
UCSB Chem Engineering
Institute for Collaborative Biotechnologies
Biomolecular Science and Engineering Program (BMSE)
Center
for Control, Dynamical Systems, & Computation
Interdepartmental Graduate Program in Marine Science (IGPM)
Computational Science and Engineering, IGERT program
|
|
|
|
Glucose Monitoring through Meal Detection
Another study looked at using continous
glucose monitoring to detect a meal. Eyal Dassau, PHD, of the University
of California, Santa Barbara, said the ability to use a meal detection
algorithm has safety and quality-of-life implications, particularly in
children and adolescents, which is why the Juvenile Diabetes
Research Foundation provided financial support for the study.
Adolescents often forget to bolus before eating, which results in very high
blood glucose levels a couple of hours after a meal, which is something we'd
like to avoid," Dr. Dassau said.
The study he presented looked at whether glucose rate-of-change data from
a continuous glucose monitor could detect a meal. Dr. Dassau said the
results indicated that the use of meal detection algorithm will trigger
a model for predictive control of insulin dosing during a meal before
there has been a major elevation in blood glucose levels. More...
|
|
|
|
| Santa Barbara researchers to test artificial pancreas More... |
| JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute More... |
| The artificial pancreas system More ... |
| Obstacles Diminish in Quest for the Artificial Pancreas More... |
| Artificial pancreas to help those with diabetes developed in Santa Barbara More... |
Open Positions
New opportunities in the lab. More...
Drug firm turns spotlight on basic systems biology-Nature
The pharmaceutical company Pfizer has
launched a three-year, US$14-million
systems-biology consortium to improve the
understanding of diabetes and obesity.
Systems biology uses computer-intensive
data analysis to deriv> models about specific
biological phenomena, and can be used to
help study the progression of some diseases.
Drug companies have traditionally shied
away from it, because it can take a long time
to see any financial pay-off. But in March,
systems-biology research, funded in part by
Merck, identified genes involved in obesity.
In the new Pfizer programme, researchers
at the University of California, Santa
Barbara, the California Institute of
Technology in Pasadena, the Massachusetts
Institute of Technology in Cambridge,
the University of Massachusetts, and
biotechnology company Entelos based in
Foster City, California, will examine the
regulatory mechanisms involved in insulin
signalling in fat cells.. More...
|
|
|
|
